WHAT WE DO?
About
Orient Gene
Securities code: 688298
Company
Introduction
Zhejiang Orient Gene Biotech Co., Ltd was established in December 2005.
01
Overview
It is a company specializing in the R&D, production and sales of in vitro diagnostic products, belonging to the field of high-end medical equipment and devices.
02
Main Products
Currently, its main products are POCT instant diagnostic reagents, which are mainly used in the detection of infectious diseases (including COVID-19 detection products), drugs of abuse, fertility, tumor marker and cardiac marker detection, among which infectious disease and drugs of abuse detection are the two core product series of the company.
03
Sales Network
The company’s sales network has been extended to more than 120 countries and regions, and its overseas sales revenue accounted for 95% in 2019. At present, the company has obtained more than 300 overseas certifications/records, and more than 70 domestic registration/record certificates.
2005
2005 Year
Established in
$1.2
$1.2 Billion
Registered capital of
120+
120+
Sales network
R&D
Future Direction

In addition to POCT instant diagnostic reagent, according to the R&D field and direction, the company continues to invest in the R&D of biological raw material platform, molecular diagnostic platform, liquid biochip platform and in vitro diagnostic instrument platform, and formulates the strategy of synchronous development of each technology platform, so as to promote the development of the company through integrated R&D mode.

DIVERSITY AND INCLUSION
Company Brand
The company has been adhering to the global development strategy and has now developed into a medical device company enjoying a high international reputation
亚洲色国产在线观看,亚洲国产精品高清在线,国内A级毛片免费观看,秋霞最新高清无码鲁丝片